Company Data
Monopar Therapeutics Inc.
Ticker
MNPR
Current Price
$35.95 -2.57%
Market Cap
$219.8M
Price Target
Refer to Report
Volume
4.1K
52wk Range
$1.719 - $54.3
Overview
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company’s pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.